US's FluMist can now be administered by a healthcare provider or by recipient or caregiver aged 18 or above. India's Nasovac S4 faces hurdles like cost, availability & low acceptance.
Mylab & Serum Institute of India launched Nasovac S4 last week. It's being seen as major step towards increasing acceptance of flu vaccines in India, where uptake has been low.
Speaking at International Science Festival in Bhopal, Krishna Ella said iNCOVACC will be launched by 26 Jan and a vaccine for lumpy skin disease, too, will be launched next month.
Nitric oxide used in nasal spray prevents SARS-CoV-2 from spreading to the lungs and can stop replication of the virus, finds study by researchers affiliated with makers of FabiSpray.
Nasal vaccines and sprays have been subject of discussion since early days of Covid, with research finally making headway into actually testing them for mucosal immunity.
The development of mucosal vaccines for Covid has been spurred on by the success of the oral polio vaccine, which induces 'mucosal immunity' in the gut.
New Delhi: The outsourcing industry, India’s largest white-collar employer, is a juggernaut that has all but stopped moving. The dollar revenue at the top...
By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.
American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.
COMMENTS